← k3vl4r
Log inGet started →

PTCT (PTC Therapeutics) Price Forecast

AI-generated price forecast for PTC Therapeutics (PTCT) across 1-hour, 4-hour, daily and weekly horizons — updated continuously, with a public accuracy track record.

The desk streams live daily· see the schedule →

As of November 2026: K3vl4r's calibrated AI forecast currently reads PTCT as 1/1 bearish across its horizons (0 of 1 timeframes pointing up), with a last price of 58.33. See our public, auditable track record →

📈 Daily Top Picks beating the S&P 500 since launch→✓ Public, verifiable track record Live system status💎 Get the full AI report · pay with XRP🔬 Deep research

Last price

58.33

AI outlook

1/1 bearish

Timeframes up

0 / 1

Share𝕏PostTelegram

PTCT forecast by horizon

HorizonDirectionCalibrated move (end of horizon)
1-hour——
4-hour——
Daily~4 weeks out▼ Down-14.64%
WeeklyNot enough track record yet—

Calibrated: each horizon's forecast is weighted by how often the model has called PTCT's direction correctly over the last 30 days, and reversed where it has been wrong more often than right. A horizon votes only once it has enough resolved forecasts.

Latest PTCT news

From the market-news feed the forecasts are read against.

  • PTC Therapeutics Sees $2 Billion-Plus Sephience Potential, Sets January Guidance Date · ldr:marketbeat.com · Nov 16
  • PTC Therapeutics Board of Directors Authorizes $500 Million Share Repurchase Program · Yahoo · Nov 3
  • PTC Therapeutics: Sephience Keeps Beating The Forecast, But The Price Already Knows · SeekingAlpha · Nov 3
  • PTC Therapeutics Board Authorizes $500M Share Repurchase Program · Benzinga · Nov 3
  • PTC Therapeutics (NASDAQ:PTCT) Stock Gets Price Target Increase from Citigroup · ldr:tickerreport.com · Nov 2

🔒

See the full PTCT forecast

Interactive forecast chart, price targets, and Monte-Carlo confidence bands — plus the daily AI Top Picks book. Free to start, no card required.

Create a free account →

Already have one? Log in

PTCT forecast — frequently asked

Will PTCT go up?

K3vl4r's calibrated AI forecast currently reads PTCT as 1/1 bearish — 0 of 1 forecast horizons point up, so the overall read is leaning to the downside. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

What is the PTCT price prediction for 2026?

K3vl4r's model projects PTCT toward $49.64 over the next ~4 weeks, a -14.6% move from $58.15. Projections update continuously as new data arrives and are inherently uncertain. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

Part of Healthcare forecasts — browse the full sector.

More AI forecasts

MGRXARVNCOSMEELVCALCZNTLHALOAGENCOGTAIMCUEEQARDXCGEN

Will PTCT reach…?

Will PTCT reach $100.00?Will PTCT reach $200.00?Will PTCT reach $250.00?

Or see the full PTCT price prediction (2027–2040), or the forecast for today, tomorrow and this week.

Compare PTCT

PTCT vs MGRXPTCT vs ARVNPTCT vs COSMPTCT vs EELVPTCT vs CALCPTCT vs ZNTL

Curious how this is generated? Read how K3vl4r forecasts — the model, the confidence bands, and what we deliberately do not claim.

K3vl4r publishes a public, auditable track record of its Daily Top Picks — see the live results.

Forecasts are model-generated estimates for informational purposes only and are not financial advice. Markets are risky; past accuracy does not guarantee future results. See our Risk Disclosure.

StreamWatch on Kick·Watch on YouTube
k3vl4rResearch libraryTrack recordChart indicatorsToday's outlookStream scheduleBiggest moversMarket heatmapForecasts by sectorAI reportsMarket videosCompareMethodologyBest AI toolsAboutFAQ◈ KVLHow KVL worksTokenomicsX (Twitter)YouTube — daily showsTikTokTwitch — live forecastingDiscord community

Join the community on Discord and catch the desk stream live on Kick or YouTube. Create a free account →

Forecasts are AI-generated; written analysis is AI-assisted and human-reviewed. Informational only, not financial advice. See Terms, Risk Disclosure, Privacy · Methodology · Status.